000 02326nam a2200469 i 4500
999 _c274902
_d274902
001 on1056246071
003 OCoLC
005 20181115094739.0
007 he bmb024bbca
008 181010s2018 dcuab bb f000 0 eng c
040 _aPUCPR
_beng
_erda
_cGPO
_dMvI
042 _apcc
043 _an-us---
074 _a1019-B-01 (MF)
086 0 _aY 4.C 73/8:115-16
088 _aSerial no. 115-16 (United States. Congress. House. Committee on Energy and Commerce)
099 _aY 4.C 73/8:115-16
110 1 _aUnited States.
_bCongress.
_bHouse.
_bCommittee on Energy and Commerce.
_bSubcommittee on Oversight and Investigations,
245 1 0 _aFentanyl :
_bthe next wave of the opioid crisis : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 21, 2017.
264 1 _aWashington :
_bU.S. Government Publishing Office,
_c2018.
264 2 _aWashington, DC :
_bFor sale by the Superintendent of Documents, U.S. Government Publishing Office
300 _aiii, 234 pages :
_billustrations, maps ;
_c24 cm
336 _btxt
337 _bh
_2rdamedia
338 _bhe
_2rdacarrier
500 _aShipping list no.: 2018-0140-M.
500 _a"Serial No. 115-16."
500 _aCRDP Program record.
504 _aIncludes bibliographical references.
533 _aMicrofiche.
_b[Washington, D.C.] :
_cU.S. Government Printing Office,
_d[2018]
_e3 microfiches : negative.
776 0 8 _iPrint version:
_aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.
_tFentanyl
_w(DLC) 2017393158
_w(OCoLC)1030308556
776 0 8 _iOnline version:
_aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.
_tFentanyl
_w(OCoLC)1030308978
050 4 _aKF27
_b.E5546 2017g
650 0 _aOpioid abuse
_zUnited States.
650 0 _aOpioid abuse
_zUnited States
_xPrevention.
650 0 _aDrug addiction
_xTreatment
_zUnited States.
650 0 _aDrugs
_xTherapeutic use
_zUnited States.
650 0 _aDrugs
_xOverdose
_zUnited States.
650 0 _aDrug control
_zUnited States.
655 7 _aLegislative hearings.
_2lcgft
942 _2sudocs
_c8